Increased LASP1 protein levels were also found in metastatic high-risk prostate carcinomas [68], metastatic colorectal carcinomas (CRC) [69,70], in clear cell renal cell carcinoma (ccRCC) tissues [71] and in bladder carcinoma (BC) specimens [72]. Here, LASP1 is linked to breast cancer.